Issue Navigation
-
Policy Forum
-
120-128
Zhang X, Luan J, Mu Y, Zhang K, Han Z, Han J
Intractable Rare Dis Res. 2026; 15(2):120-128.
DOI: 10.5582/irdr.2025.01060
-
129-134
From presence to provenance: Building substantive infrastructure for China's rare disease ecosystem
Yang R
Intractable Rare Dis Res. 2026; 15(2):129-134.
DOI: 10.5582/irdr.2026.01019
-
135-143
Wang M, Rong CY, Wang PY
Intractable Rare Dis Res. 2026; 15(2):135-143.
DOI: 10.5582/irdr.2026.01001
-
144-155
Beyond malignancies: Clinical advancements of CAR T-cell in the treatment of autoimmune diseases
Fang X, Wei R, Zhu W, Hu Y, Liang H
Intractable Rare Dis Res. 2026; 15(2):144-155.
DOI: 10.5582/irdr.2025.01057
-
156-165
Han Y, Zhou C, Wang P, Karako K, Song PP
Intractable Rare Dis Res. 2026; 15(2):156-165.
DOI: 10.5582/irdr.2026.01043
-
166-172
Mitsoudis N, Nikolakakis I, Apsemidou A, Bakirtzis C, Grigoriadis N
Intractable Rare Dis Res. 2026; 15(2):166-172.
DOI: 10.5582/irdr.2026.01013
-
173-182
Li L, Chen Y, He Z, Li Q, Huang R
Intractable Rare Dis Res. 2026; 15(2):173-182.
DOI: 10.5582/irdr.2025.01074
-
183-193
Hu Y, Gao S, Jiang H, Huo Y, Liu Y, Yang R, Liu W, Cao Y, Duan W, Tang H
Intractable Rare Dis Res. 2026; 15(2):183-193.
DOI: 10.5582/irdr.2026.01006
-
194-199
Salinas-Torres VM, Salinas-Torres RA
Intractable Rare Dis Res. 2026; 15(2):194-199.
DOI: 10.5582/irdr.2026.01011
-
E1
Intractable Rare Dis Res. 2026; 15(2):E1.
DOI: 10.5582/irdr.2026.E1
Summary
Full Text (PDF)




